Ethyl-(1,3-dimethyl-but-2-enyl)-ether | 63387-27-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Ethyl-(1,3-dimethyl-but-2-enyl)-ether
• 英文别名: 4-ethoxy-2-methyl-pent-2-ene；4-Aethoxy-2-methyl-pent-2-en；4-Ethoxy-2-methylpent-2-ene
• CAS: 63387-27-9
• 化学式: C₈H₁₆O
• 分子量: 128.214
• InChiKey: YJIZKBZBSJGRSJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2-methyl-2,4-dibromopentane 、 乙醇 在 氢氧化钾 作用下， 生成 Ethyl-(1,3-dimethyl-but-2-enyl)-ether
  参考文献：
  名称：

  Ipatjew, Journal fur praktische Chemie (Leipzig 1954), 1899, vol. <2>59, p. 543

  摘要：

  DOI：

文献信息

• Cerium(IV), as a selective and efficient catalyst for alcoholyses of allylic and tertiary benzylic alcohols
  作者：Nasser Iranpoor、Enayatholah Mothaghineghad

  DOI：10.1016/s0040-4020(01)80857-7

  日期：1994.1

  An efficient and selective method is described for the catalytic conversion of allylic, and tertiary benzylic alcohols into their corresponding ethers in the presence of Ce(IV) under solvolytic and non-solvolytic conditions.

  描述了一种有效且选择性的方法，用于在溶剂化和非溶剂化条件下在Ce（IV）存在下将烯丙基和叔苄醇催化转化为相应的醚。
• Catalytic and efficient cleavage of allylic and tertiary benzylic ethers and esters with Ce(IV)
  作者：Nasser Iranpoor、Enayatolah Mottaghinejad

  DOI：10.1016/s0040-4020(01)85253-4

  日期：1994.1

  The reaction of cerium(IV) as ceric ammonium nitrate (CAN) with a variety of allylic and tertiary benzylic ethers and esters has been examined in different alcohols and acetic acid under catalytic and mild conditions. Experiments have been conducted to elucidate the scope of this ether-to-ether, ether-to-acetate and acetate-to-ether transformations.

  铈（IV）作为硝酸铈铵（CAN）与各种烯丙基和叔苄基醚和酯的反应已在催化和温和条件下的不同醇和乙酸中进行了研究。已经进行了实验以阐明该醚到醚，醚到乙酸酯和乙酸酯到醚的转化的范围。
• Enhanced Osteogenic Activity of Daidzein Analogs on Human Mesenchymal Stem Cells
  申请人：THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND

  公开号：US20160068542A1

  公开（公告）日：2016-03-10

  Disclosed are daidzein analogs having the formula (I). Also disclosed are compositions, include a disclosed daidzein analogs, methods of preventing or treating bone disease or bone injury and/or stimulating bone growth, in a subject that include administering to the subject an effective amount of disclosed daidzein analog. Disclosed are isolated mesenchymal stem cell that has been altered by treatment a disclosed daidzein analog, daidzein, glycinol, glyceollin I, or glyceollin II, to increase the osteogenic potential of the mesenchymal stem cells.

  本发明揭示了具有公式（I）的daidzein类似物。还揭示了包括所述daidzein类似物的组合物，用于预防或治疗骨疾病或骨损伤和/或刺激骨生长的方法，包括向受体施用揭示的daidzein类似物的有效量。本发明揭示了已通过处理揭示的daidzein类似物，daidzein，glycinol，glyceollin I或glyceollin II而改变的分离的间充质干细胞，以增加间充质干细胞的成骨潜能。
• Iranpoor Nasser, Mothaghineghad Enayatholah, Tetrahedron, 50 (1994) N 6, S 1859-1870
  作者：Iranpoor Nasser, Mothaghineghad Enayatholah

  DOI：——

  日期：——